Investigating the novel acetonitrile derivatives as potential SARS-CoV-2 main protease inhibitor using molecular modeling approach

References

• BIOVIA, D. S. (2017). Discovery Studio Modeling Environment, Release.
   Google Scholar
• Barret, R. (2018). Lipinski’s rule of five. In Therapeutical Chemistry, 97–100. https://doi.org/10.1016/b978-1-78548-288-5.50006-8
   Google Scholar
• Bello, M. (2020). Prediction of potential inhibitors of the dimeric SARS-CoV2 main proteinase through the MM/GBSA approach. Journal of Molecular Graphics & Modelling, 101, 107762. https://doi.org/10.1016/j.jmgm.2020.107762
   PubMed Web of Science ®Google Scholar
• Cardoso, W. B., & Mendanha, S. A. (2021). Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors. Journal of Molecular Structure, 1225, 129143. https://doi.org/10.1016/j.molstruc.2020.129143
   PubMed Web of Science ®Google Scholar
• Case, D. A., Walker, R. C., Cheatham, T. E., Simmerling, C., Roitberg, A., Merz, K. M., … Darden, T. (2018). Amber 18: Reference manual. University of California.
   Google Scholar
• Cho, C. C., Li, S. G., Lalonde, T. J., Yang, K. S., Yu, G., Qiao, Y., … Ray Liu, W. (2022). Drug repurposing for the SARS-CoV-2 papain-like protease. ChemMedChem, 17, e202100455. https://doi.org/10.1002/cmdc.202100455
   Google Scholar
• Cousins, K. R. (2011). Computer review of ChemDraw ultra 12.0 ChemDraw ultra 12.0. CambridgeSoft, 100 Cambridge Park Drive, Cambridge, MA 02140.. Journal of the American Chemical Society, 21, 8388. https://doi.org/10.1021/ja204075s
   Google Scholar
• Cui, W., Yang, K., & Yang, H. (2020). Recent progress in the drug development targeting SARS-CoV-2 main protease as treatment for COVID-19. Frontiers in Molecular Biosciences, 7, 616341. https://doi.org/10.3389/fmolb.2020.616341
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• de Oliveira, O. V., Rocha, G. B., Paluch, A. S., & Costa, L. T. (2020). Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. Journal of Biomolecular Structure and Dynamics, 39(11), 3924-3933. https://doi.org/10.1080/07391102.2020.1772885
   Google Scholar
• DeLano, W. L. (2002). The PyMOL molecular graphics system. Version 1.1. Schrödinger LLC, http://www.pymol.org. https://doi.org/10.1038/hr.2014.17
   Google Scholar
• Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., … Zhong, N. S. (2020). Clinical characteristics of 2019 novel coronavirus Disease 2019 in China. The New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032.
   Google Scholar
• Hanwell, M., Curtis, D., Lonie, D., Vandermeersch, T., Zurek, E., & Hutchison, G. (2012). Avogadro: An advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4, 1–17. https://doi.org/10.1186/1758-2946-4-17
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Kumar, Y., Singh, H., & Patel, C. N. (2020). In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health, 13(9), 1210–1223. https://doi.org/10.1016/j.jiph.2020.06.016
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A, Open Source Drug Discovery Consortium. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Kumbhar, B. V., Bhandare, V. V., Panda, D., & Kunwar, A. (2020). Delineating the interaction of combretastatin A-4 with αβ tubulin isotypes present in drug resistant human lung carcinoma using a molecular modeling approach. Journal of Biomolecular Structure and Dynamics, 38(2), 426–438. https://doi.org/10.1080/07391102.2019.1577174
   PubMed Web of Science ®Google Scholar
• Kumbhar, B. V., Borogaon, A., Panda, D., & Kunwar, A. (2016). Exploring the origin of differential binding affinities of human tubulin isotypes αβII, αβIII and αβIV for DAMA-colchicine using homology modelling, molecular docking and molecular dynamics simulations. PLoS One, 11(5), e0156048. https://doi.org/10.1371/journal.pone.0156048
   PubMed Web of Science ®Google Scholar
• Langer, T., & Hoffmann, R. (2001). Virtual screening an effective tool for lead structure discovery. Current Pharmaceutical Design, 7(7), 509–527. https://doi.org/10.2174/1381612013397861
   PubMed Web of Science ®Google Scholar
• Meng, X.-Y., Zhang, H.-X., Mezei, M., & Cui, M. (2011). Molecular docking: A powerful approach for structure-based drug discovery. Current Computer Aided-Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An efficient program for end-state free energy calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Ruth, H., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). Software news and updates AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Muniyappa, R., & Gubbi, S. (2020). COVID-19 pandemic, coronaviruses, and diabetes mellitus. American Journal of Physiology – Endocrinology and Metabolism, 318, E736–E741. https://doi.org/10.1152/ajpendo.00124.2020
   Google Scholar
• Patil, V. S., Nandre, K. P., Ghosh, S., Rao, V. J., Chopade, B. A., Bhosale, S. V., & Bhosale, S. V. (2012). Synthesis and glycosidase inhibitory activity of novel (2-phenyl-4H-benzopyrimedo[2,1-b]-thiazol-4-yliden)acetonitrile derivatives. Bioorganic and Medicinal Chemistry Letters, 22(23), 7011-4. https://doi.org/10.1016/j.bmcl.2012.10.025
   Google Scholar
• Swails, J., Hernandez, C., Mobley, D. L., Nguyen, H., Wang, L. P., & Janowski, P. (n.d.). ParmEd. https://github.com/ParmEd/ParmEd (Accessed October 9, 2015)
   Google Scholar
• Tatar, G., Salmanli, M., Dogru, Y., & Tuzuner, T. (2021). Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/10.1080/07391102.2021.1900919
   Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11), 1061. https://doi.org/10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2020). Listings of WHO’s response to COVID-19. World Health Organization.
   Google Scholar
• Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L., & Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B, 10(5), 766–788. https://doi.org/10.1016/j.apsb.2020.02.008
   PubMed Web of Science ®Google Scholar
• Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science, 367(6485), 1444–1448. https://doi.org/10.1126/science.abb2762
   PubMed Web of Science ®Google Scholar
• Yu, R., Chen, L., Lan, R., Shen, R., & Li, P. (2020). Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking. International Journal of Antimicrobial Agents, 56(2), 106012. https://doi.org/10.1016/j.ijantimicag.2020.106012
   PubMed Web of Science ®Google Scholar
• Zhu, L., She, Z.-G., Cheng, X., Qin, J.-J., Zhang, X.-J., Cai, J., Lei, F., Wang, H., Xie, J., Wang, W., Li, H., Zhang, P., Song, X., Chen, X., Xiang, M., Zhang, C., Bai, L., Xiang, D., Chen, M.-M., … Li, H. (2020). Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes. Cell Metabolism, 31(6), 1068–1077.e3. https://doi.org/10.1016/j.cmet.2020.04.021
   PubMed Web of Science ®Google Scholar
• Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K. Y. (2016). Coronaviruses-drug discovery and therapeutic options. Nature Reviews Drug Discovery, 15(5), 327–347. https://doi.org/10.1038/nrd.2015.37
   PubMed Web of Science ®Google Scholar